Skip Nav Destination
Close Modal
Search Results for
fraud
Update search
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Authors
- Author Affiliations
- Full Text
- Abstract
- Keywords
- DOI
- ISBN
- eISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-20 of 252 Search Results for
fraud
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Article
J Health Polit Policy Law (1986) 10 (4): 786–788.
Published: 01 August 1986
... of the
persistent struggles by disabled citizens to gain liberty and equality under the
American Constitution.
University of Southern Calijornia Harlan Hahn
John A. Gardiner and Theodore R. Lyman, The Fraud Control Game (Bloom-
ington, Ind.: Indiana University Press, 1984), 266 pp...
Journal Article
J Health Polit Policy Law (2024) 49 (2): 249–268.
Published: 01 April 2024
...Liam Bendicksen; Aaron S. Kesselheim; C. Joseph Ross Daval Abstract Context: The False Claims Act is the US federal government's primary tool for identifying and penalizing pharmaceutical fraud. The Department of Justice uses the False Claims Act to bring civil cases against drug manufacturers...
FIGURES
| View All (8)
Image
in Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006–2022
> Journal of Health Politics, Policy and Law
Published: 01 April 2024
Figure 1 Federal fraud settlements involving pharmaceutical manufacturers, 2006–2022. Source : US Department of Justice press releases.
More
Image
in Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006–2022
> Journal of Health Politics, Policy and Law
Published: 01 April 2024
Figure 2 Totality of federal fraud settlement payments involving pharmaceutical manufacturers. Note : All values in January 2023 dollars. Source : US Department of Justice press releases.
More
Image
in Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006–2022
> Journal of Health Politics, Policy and Law
Published: 01 April 2024
Figure 5 Alleged fraud attributed to nervous system drugs, 2006–2022. Source : US Department of Justice press releases.
More
Image
in Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006–2022
> Journal of Health Politics, Policy and Law
Published: 01 April 2024
Figure 6 Alleged fraud attributed to cardiovascular system drugs, 2006–2022. Source : US Department of Justice press releases.
More
Image
in Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006–2022
> Journal of Health Politics, Policy and Law
Published: 01 April 2024
Figure 7 Alleged fraud attributed to antineoplastic and immunomodulating agents, 2006–2022. Source : US Department of Justice press releases.
More
Image
in Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006–2022
> Journal of Health Politics, Policy and Law
Published: 01 April 2024
Figure 8 Alleged fraud attributed to alimentary tract and metabolism drugs, 2006–2022. Note : NDA = new drug application. Source : US Department of Justice press releases.
More
Journal Article
J Health Polit Policy Law (2000) 25 (2): 283–308.
Published: 01 April 2000
...John C. Ruhnka; Edward J. Gac; Heidi Boerstler The Department of Justice (DOJ) reports that after violent crime, health care fraud is the department's top priority. The number of health care fraud investigations pending at the DOJ increased from 270 cases in 1992 to more than 4,000 in 1997...
Journal Article
J Health Polit Policy Law (2010) 35 (1): 5–28.
Published: 01 February 2010
...Leighton Ku; Fouad Pervez In 2006 Congress passed, and the Centers for Medicare and Medicaid Services (CMS) rapidly issued, regulations requiring states to obtain proof of citizenship from citizens who had applied for Medicaid. This policy was framed as reducing fraud by illegal aliens to preserve...
Journal Article
J Health Polit Policy Law (1994) 19 (1): 7–26.
Published: 01 February 1994
... are driven by concerns about cost control, the carriers' actual review process relies on aggregate utilization and spending targets that have little to do with clinical guidelines. The carriers' medical review rhetoric using the terms medically unnecessary and fraud and abuse as synonymsalso highlights...
Journal Article
J Health Polit Policy Law (1988) 13 (4): 607–621.
Published: 01 August 1988
... test is ordered. When the test is ordered to protect health care workers rather than to benefit the patient, the patient must be informed of the true purpose of the test; special care must be taken to avoid claims of fraud or duress that might invalidate the patient's consent. Furthermore, testing...
Journal Article
J Health Polit Policy Law (2020) 45 (3): 419–437.
Published: 01 June 2020
...David Howard Abstract Context: Overtreatment is costly, but is it fraud? In a growing number of False Claims Act cases, the Department of Justice has sought and received multimillion dollar settlements from providers accused of billing Medicare for unnecessary care. This article evaluates the use...
FIGURES
Image
Published: 01 June 2020
Figure 1 New health care False Claims Act cases. Source : Civil Division, US Department of Justice. Fraud Statistics—Overview, www.justice.gov/opa/press-release/file/918361/download .
More
Journal Article
J Health Polit Policy Law (1986) 10 (4): 788–792.
Published: 01 August 1986
...George A. Silver 788 Journal of Health Politics, Policy and Law
Second, the determination of an appropriate level of fraud control is compli-
cated by the difficulty of assigning weights to the political value of fraud control
relative to competing objectives, such as increasing welfare...
Journal Article
J Health Polit Policy Law (1994) 19 (4): 919–921.
Published: 01 August 1994
... the University of California, Irvine
School of Social Ecology, set out to answer these questions in their
thorough study of Medicaid fraud and abuse. By fraud, they mean out-
right lying and cheating; by abuse, they mean essentially not following all
the rules. There is a huge gulf of moral distinction...
Journal Article
J Health Polit Policy Law (2011) 36 (3): 583–589.
Published: 01 June 2011
...Peter D. Jacobson; Laura M. Napiewocki; Leah A. Voigt © 2011 by Duke University Press 2011 References American Health Lawyers Association (AHLA) . 2009 . Fraud and Abuse: Do Current Laws Protect the Public Interest? White Paper . Washington, DC : AHLA . Epstein R...
Journal Article
J Health Polit Policy Law (1986) 10 (4): 783–786.
Published: 01 August 1986
... in the critical context of the
persistent struggles by disabled citizens to gain liberty and equality under the
American Constitution.
University of Southern Calijornia Harlan Hahn
John A. Gardiner and Theodore R. Lyman, The Fraud Control Game (Bloom-
ington, Ind.: Indiana...
Journal Article
J Health Polit Policy Law (1994) 19 (1): 265–268.
Published: 01 February 1994
... of their patients) has
recently moved from the shadows of ethical discourse to the crowded
center stage of health policy. Vigorous enforcement of the Medicare and
Medicaid fraud and abuse laws, accompanied by the wide dissemination
of “fraud alerts,” has made painfully clear the prevalence of kickbacks...
Journal Article
J Health Polit Policy Law (2001) 26 (6): 1412–1415.
Published: 01 December 2001
... be listed and in what order they should appear. Contribu-
tors to the volume also discuss “gift authorship” and the “imagined
author.”
Particularly useful is the discussion on the role of the “gift author” in
cases in which questions of fraud arise. If, for example...
1